These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36545274)

  • 1. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.
    Wei W; Wang J; Hu Y; Chen S; Liu J
    Exp Ther Med; 2023 Jan; 25(1):7. PubMed ID: 36545274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.
    Wei W; Wang L; Xu L; Liang J; Teng L
    ACS Omega; 2021 Nov; 6(47):31435-31446. PubMed ID: 34869970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
    Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].
    An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y
    Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail.
    Zhang S; Zhang XQ; Huang SL; Chen M; Shen SS; Ding XW; Lv Y; Zou XP
    Pancreas; 2015 Oct; 44(7):1121-9. PubMed ID: 26348464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine.
    Yu Y; Ding F; Gao M; Jia YF; Ren L
    Oncol Lett; 2019 Sep; 18(3):3065-3071. PubMed ID: 31452783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ
    Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
    Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
    Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
    Deng K; Zou F; Xu J; Xu D; Luo Z
    Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study].
    Liu A; Luo J; Zhang JH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):652-6. PubMed ID: 22679728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
    Li N; Wang C; Zhang P; You S
    Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z
    Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
    Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
    Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between the radioresistance of pancreatic cancer cell SW1990 and the induction of the Epithelial-Mesenchymal Transition: an in vitro study].
    Jiang YH; You KY; Bi ZF; Li LT; Mo HQ; Liu YM
    Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):939-943. PubMed ID: 29665670
    [No Abstract]   [Full Text] [Related]  

  • 17. Emodin: One Main Ingredient of Shufeng Jiedu Capsule Reverses Chemoresistance of Lung Cancer Cells Through Inhibition of EMT.
    Ying Y; Qingwu L; Mingming X; Zhenju S; Chaoyang T; Zhengang T
    Cell Physiol Biochem; 2017; 42(3):1063-1072. PubMed ID: 28662514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on anti-metastasis effect of emodin on human pancreatic cancer].
    Liu A; Sha L; Shen Y; Huang L; Tang X; Lin S
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(22):3167-71. PubMed ID: 22375400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
    Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
    Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.